PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35258781-7	2022	RESULTS: LPS could obviously stimulate GMCs proliferation, elevate SphK1, p-c-Jun and TGF-beta1 expression levels and increase the DNA-binding activity of AP-1 (P<0.05 or P<0.01), whereas these effects were significantly blocked by RSV pretreatment.	Resveratrol	232-235	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	155-159	
35529447-0	2022	Mosloflavone-Resveratrol Hybrid TMS-HDMF-5z Exhibits Potent In Vitro and In Vivo Anti-Inflammatory Effects Through NF-kappaB, AP-1, and JAK/STAT Inactivation.	Resveratrol	13-24	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	126-130	
35258781-1	2022	OBJECTIVE: To elucidate the renoprotective effect of resveratrol (RSV) on sphingosine kinase 1 (SphK1) signaling pathway and expression of its downstream molecules including activator protein 1 (AP-1) and transformation growth factor-beta1 (TGF-beta1) in lipopolysaccharide (LPS)-induced glomerular mesangial cells (GMCs).	Resveratrol	53-64	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	174-193	
35258781-1	2022	OBJECTIVE: To elucidate the renoprotective effect of resveratrol (RSV) on sphingosine kinase 1 (SphK1) signaling pathway and expression of its downstream molecules including activator protein 1 (AP-1) and transformation growth factor-beta1 (TGF-beta1) in lipopolysaccharide (LPS)-induced glomerular mesangial cells (GMCs).	Resveratrol	53-64	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	195-199	
35258781-1	2022	OBJECTIVE: To elucidate the renoprotective effect of resveratrol (RSV) on sphingosine kinase 1 (SphK1) signaling pathway and expression of its downstream molecules including activator protein 1 (AP-1) and transformation growth factor-beta1 (TGF-beta1) in lipopolysaccharide (LPS)-induced glomerular mesangial cells (GMCs).	Resveratrol	66-69	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	174-193	
35258781-1	2022	OBJECTIVE: To elucidate the renoprotective effect of resveratrol (RSV) on sphingosine kinase 1 (SphK1) signaling pathway and expression of its downstream molecules including activator protein 1 (AP-1) and transformation growth factor-beta1 (TGF-beta1) in lipopolysaccharide (LPS)-induced glomerular mesangial cells (GMCs).	Resveratrol	66-69	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	195-199	
26499206-8	2015	Resveratrol inhibited diabetes-induced increases in AP-1 (activator protein-1) components, c-Jun and ATF2 (activating transcription factor 2), but not their phosphorylated forms, to normal control levels (P&lt;0.05).	Resveratrol	0-11	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	52-56	
26499206-8	2015	Resveratrol inhibited diabetes-induced increases in AP-1 (activator protein-1) components, c-Jun and ATF2 (activating transcription factor 2), but not their phosphorylated forms, to normal control levels (P&lt;0.05).	Resveratrol	0-11	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	58-77	
24549589-9	2014	Resveratrol prevented IkappaB degradation (except for 6 h) and decreased nuclear factor-kappaB (NF-kappaB), activator protein-1 (AP-1) (except for 24 h), and levels of TNF-alpha, IL-6 (except for 24 h), and iNOS in the pancreatic tissue at all time points (P &lt; 0.05).	Resveratrol	0-11	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	108-127	
24549589-9	2014	Resveratrol prevented IkappaB degradation (except for 6 h) and decreased nuclear factor-kappaB (NF-kappaB), activator protein-1 (AP-1) (except for 24 h), and levels of TNF-alpha, IL-6 (except for 24 h), and iNOS in the pancreatic tissue at all time points (P &lt; 0.05).	Resveratrol	0-11	Jun proto-oncogene, AP-1 transcription factor subunit	Rattus norvegicus	129-133